Company intelligence / Profile preview

Liaoning Yikang Biological Co., Ltd.

Liaoyang, Liaoning, Chinaen.lnyk.net ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

The company has multiple commercial animal vaccines including avian influenza, classical swine fever, and rabies vaccines. Their products have been sold domestically in China and exported to countries including Egypt, Nigeria, Myanmar, and Iran.

Therapeutic areas: Infectious Diseases
Modalities: VaccinesTherapeutic antibodies
Industry: Veterinary

Drug pipeline

3 assets

H5+H7 trivalent avian influenza vaccine

Commercial

Indications: Avian influenza

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Liaoning Yikang Biological Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liaoning Yikang Biological Co., Ltd..

Explore the full profile